CardioKinetix Inc., a Redwood City, Calif.-based heart failure treatment company, secured $14.5 million in Series C funding led by Cutlass Capital, JPMorgan Partners and
CardioKinetix Inc., a Redwood City, Calif.-based heart failure treatment company, secured $14.5 million in Series C funding led by Cutlass Capital, JPMorgan Partners and
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.